Prognostic Impact of Urine Protein in Diabetic Patients with Ischemic Heart Failure-A Report from the CHART-2 Study-

Masanobu Miura; Yasuhiko Sakata; Satoshi Miyata; Kotaro Nochioka; Tsuyoshi Takada; Soichiro Tadaki; Jun Takahashi; Hiroaki Shimokawa

doi:10.1016/j.cardfail.2013.08.182

Prognostic Impact of Urine Protein in Diabetic Patients with Ischemic Heart Failure-A Report from the CHART-2 Study-

Masanobu Miura
, Yasuhiko Sakata
, Satoshi Miyata
, Kotaro Nochioka
, Tsuyoshi Takada
, Soichiro Tadaki
, Jun Takahashi
, Hiroaki Shimokawa

Graduate School of Public Health

Research output: Contribution to journal › Article

Original language	English
Journal	JOURNAL OF CARDIAC FAILURE
Volume	19
Issue number	10
DOIs	https://doi.org/10.1016/j.cardfail.2013.08.182
State	Published - Oct 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.cardfail.2013.08.182License: Unspecified

Cite this

@article{772ff9923d804172bd7de8c5a0901b34,

title = "Prognostic Impact of Urine Protein in Diabetic Patients with Ischemic Heart Failure-A Report from the CHART-2 Study-",

author = "Masanobu Miura and Yasuhiko Sakata and Satoshi Miyata and Kotaro Nochioka and Tsuyoshi Takada and Soichiro Tadaki and Jun Takahashi and Hiroaki Shimokawa",

year = "2013",

month = oct,

doi = "10.1016/j.cardfail.2013.08.182",

language = "英語",

volume = "19",

journal = "JOURNAL OF CARDIAC FAILURE",

issn = "1071-9164",

number = "10",

}

TY - JOUR

T1 - Prognostic Impact of Urine Protein in Diabetic Patients with Ischemic Heart Failure-A Report from the CHART-2 Study-

AU - Miura, Masanobu

AU - Sakata, Yasuhiko

AU - Miyata, Satoshi

AU - Nochioka, Kotaro

AU - Takada, Tsuyoshi

AU - Tadaki, Soichiro

AU - Takahashi, Jun

AU - Shimokawa, Hiroaki

PY - 2013/10

Y1 - 2013/10

U2 - 10.1016/j.cardfail.2013.08.182

DO - 10.1016/j.cardfail.2013.08.182

M3 - 記事

SN - 1071-9164

VL - 19

JO - JOURNAL OF CARDIAC FAILURE

JF - JOURNAL OF CARDIAC FAILURE

IS - 10

ER -